Obesity is associated with increased risk of Crohn's disease, but not ulcerative colitis: A pooled analysis of five prospective cohort studies.

[1]  M. Neovius,et al.  Adult height in patients with childhood‐onset inflammatory bowel disease: a nationwide population‐based cohort study , 2020, Alimentary pharmacology & therapeutics.

[2]  A. Wolk,et al.  No Association Between Consumption of Sweetened Beverages and Risk of Later‐Onset Crohn's Disease or Ulcerative Colitis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  T. Sørensen,et al.  Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population‐based cohort study , 2018, The American Journal of Gastroenterology.

[4]  M. Andersson,et al.  Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National Birth Cohort , 2018, PloS one.

[5]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[6]  Rickard Ljung,et al.  Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG) , 2017, Scandinavian journal of gastroenterology.

[7]  Tran Quoc Bao,et al.  Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants , 2016, The Lancet.

[8]  Luzia Valentini,et al.  Visceral Adipose Tissue in Patients with Crohn's Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome , 2015, Inflammatory bowel diseases.

[9]  J. Halfvarson,et al.  Physical Fitness in Adolescence and Subsequent Inflammatory Bowel Disease Risk , 2015, Clinical and Translational Gastroenterology.

[10]  A. Ananthakrishnan,et al.  Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis , 2015, Inflammatory bowel diseases.

[11]  Y. Shoenfeld,et al.  Obesity in autoimmune diseases: not a passive bystander. , 2014, Autoimmunity reviews.

[12]  A. Linneberg,et al.  Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. , 2014, International journal of epidemiology.

[13]  J. Ruel,et al.  IBD across the age spectrum—is it the same disease? , 2014, Nature Reviews Gastroenterology &Hepatology.

[14]  W. Willett,et al.  A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. , 2013, Gastroenterology.

[15]  W. Willett,et al.  Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease , 2013, Gut.

[16]  E. Riboli,et al.  Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study) , 2013, The American Journal of Gastroenterology.

[17]  J. Moreno-Navarrete,et al.  Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance , 2012, PloS one.

[18]  A. Ananthakrishnan,et al.  Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis , 2012, Annals of Internal Medicine.

[19]  B. Fagerberg,et al.  Intestinal Permeability Is Associated With Visceral Adiposity in Healthy Women , 2011, Obesity.

[20]  L. Gilardini,et al.  Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? , 2011, Gut.

[21]  M. Mendall,et al.  Is Obesity a Risk Factor for Crohn’s Disease? , 2011, Digestive Diseases and Sciences.

[22]  Yikyung Park,et al.  Body-mass index and mortality among 1.46 million white adults. , 2010, The New England journal of medicine.

[23]  Vittorio Krogh,et al.  Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. , 2006, American journal of epidemiology.

[24]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Tim D. Spector,et al.  Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences , 2004, Circulation.

[26]  A. Poullis,et al.  Bowel Inflammation as Measured by Fecal Calprotectin , 2004, Cancer Epidemiology Biomarkers & Prevention.

[27]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.